He is the chief executive and founder of Ipso Ventures plc, a creator and investor in early stage technology and healthcare businesses. Nick is also chairman of Oxford BioMedica plc, a leading gene based biopharmaceutical company.
Prior to founding IPSO in 2005 Nick was an investment banker and joint head of corporate finance with Evolution Securities (formerly Beeson Gregory). Has advised on over 100 acquisitions or disposals, some 40 flotations and in excess of 20 takeovers.
Nick is also a non executive director of oncology drug developer Morvus Technology and bio ethanol developer TMO Renewables.